The Hubble Problem: Scientists Try To Pick Up The Pieces

As the shock over the mirror defect in the Hubble Space Telescope begins to wear off, some 1,000 astronomers, many of whom had anticipated funding from NASA and all of whom expected unprecedented pictures and data from the $1.6 billion instrument, are trying to salvage their research plans. Scientists at NASA headquarters in Washington D.C., the Space Telescope Science Institute (STSI) in Baltimore, the Goddard Space Flight Center in Greenbelt, Md., and here throughout the world are analyzing

Written byRobin Eisner
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

As the shock over the mirror defect in the Hubble Space Telescope begins to wear off, some 1,000 astronomers, many of whom had anticipated funding from NASA and all of whom expected unprecedented pictures and data from the $1.6 billion instrument, are trying to salvage their research plans.

Scientists at NASA headquarters in Washington D.C., the Space Telescope Science Institute (STSI) in Baltimore, the Goddard Space Flight Center in Greenbelt, Md., and here throughout the world are analyzing results of extensive testing of the telescope while re-evaluating their projects so that observation time on the telescope can be rescheduled and funding can be reworked. At the same time, astronomers and administrators alike are trying to squeeze as much good science as possible out of the scope in its current state.

Only the fine guidance sensors used to point the Hubble telescope and measure star positions are not affected by the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies